Analyst Ranking
Top 10%
#470 out of 4861 analysts
Average Return
+8.28%
Win Rate
52%55 out of 105
Risk vs Reward
Poor
Good

Catherine Schulte's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nanostring Technologies IncNSTGQ
+172.99%$25.14$68.63
2020-04-07 -
2021-04-07
Buy
Exact Sciences CorpEXAS
+117.49%$44.37$96.50
2018-02-27 -
2019-02-27
Buy
Castle Biosciences IncCSTL
+112.13%$28.27$59.97
2020-03-27 -
2021-03-26
Buy
Nanostring Technologies IncNSTGQ
+106.07%$14.00$28.85
2018-06-04 -
2019-06-04
Buy
Nanostring Technologies IncNSTGQ
+96.15%$7.79$15.28
2017-11-03 -
2018-11-02
Buy

Catherine Schulte Analyst Color

Get additional color on Catherine Schulte's coverage of popular stocks

Catherine Schulte's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Agilent Technologies IncA
16Buy$159.00+55.15%Maintains
2 months ago
Maravai Lifesciences Holdings IncMRVI
5Hold$3.00+69.49%Downgrades
2 months ago
Bio Techne CorpTECH
10Hold$68.00+41.37%Downgrades
2 months ago
Qiagen NvQGEN
3Hold$42.00+3.17%Downgrades
2 months ago
Mettler Toledo International IncMTD
7Hold$1,369.00+36.22%Maintains
2 months ago
Danaher CorpDHR
7Buy$258.00+38.09%Maintains
3 months ago
Exact Sciences CorpEXAS
11Buy$67.00+61.14%Maintains
6 months ago
Avantor IncAVTR
10Buy$26.00+72.19%Maintains
6 months ago
Thermo Fisher Scientific IncTMO
22Buy$622.00+45.50%Maintains
6 months ago
Revvity IncRVTY
5Buy$165.00N/AMaintains
2 years ago
Castle Biosciences IncCSTL
4Buy$38.00N/AMaintains
2 years ago
Twist Bioscience CorpTWST
2Buy$33.00N/AMaintains
2 years ago
Biora Therapeutics IncBIOR
1Hold$2.00N/ADowngrades
4 years ago
Chembio Diagnostics IncCEMI
1Buy$21.00N/AInitiates Coverage On
5 years ago
Illumina IncILMN
4Hold$310.00N/ADowngrades
5 years ago
Nanostring Technologies IncNSTGQ
5Buy$29.00N/AMaintains
5 years ago
Waters CorpWAT
5Hold$211.00N/ADowngrades
6 years ago
Natera IncNTRA
1Buy$20.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.